Date: August 17, 2026
Board Meeting Outcomes
- The Nomination and Remuneration Committee approved the grant of stock options under the ESOP Plan on August 17, 2026
- The grant is effective from August 18, 2026
- The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
ESOP Details
Grant Summary:
- Total options granted: 50,226 stock options
- Each stock option is convertible into one equity share of face value ₹10 each
- Total shares covered: 50,226 equity shares
Pricing Details:
- Exercise price: ₹221 per option
- Pricing formula: As per SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
Vesting Schedule:
- 4-year graded vesting period:
- 25% (12,556.5 options) on August 18, 2027 (Year 1)
- 25% (12,556.5 options) on August 18, 2028 (Year 2)
- 25% (12,556.5 options) on August 18, 2029 (Year 3)
- 25% (12,556.5 options) on August 18, 2030 (Year 4)
Exercise Period:
- 2 years from the date of vesting of each tranche
Regulatory Compliance:
- The scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
- The ESOP Plan is administered and implemented by the Nomination and Remuneration Committee
- Note: Requirements under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 updated as on January 30, 2026 are not applicable
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Financial Results
Not Specified
Disinvestment / Strategic Actions
Not Specified
Other Operational / Legal / Strategic Disclosures
- Date and time of occurrence of the event: August 17, 2026 at 20:43 hrs (IST)
- The disclosure is signed by Abhishek Mishra, Company Secretary & Compliance Officer